William Blair Lowers Earnings Estimates for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - William Blair dropped their Q2 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a note issued to investors on Thursday, February 27th. William Blair analyst B. Vazquez now expects that the medical instruments supplier will post earnings per share of $0.44 for the quarter, down from their prior forecast of $0.52. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA's Q3 2025 earnings at $0.51 EPS, FY2025 earnings at $1.80 EPS, Q2 2026 earnings at $0.47 EPS, Q3 2026 earnings at $0.54 EPS, Q4 2026 earnings at $0.61 EPS and FY2026 earnings at $1.93 EPS.

Other research analysts also recently issued research reports about the stock. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price target for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Mizuho began coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a "neutral" rating and a $21.00 target price for the company. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating on the stock in a research report on Friday, February 28th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Finally, Barrington Research decreased their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Eleven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average target price of $23.58.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded up $0.11 during trading hours on Monday, reaching $16.26. 2,609,787 shares of the company were exchanged, compared to its average volume of 2,605,293. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The firm has a market cap of $3.23 billion, a PE ratio of -7.86, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a twelve month low of $15.47 and a twelve month high of $34.28. The stock's 50-day moving average is $18.65 and its 200-day moving average is $21.28.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.94%. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.52% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of XRAY. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $27,000. Kennebec Savings Bank acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at approximately $35,000. Colonial Trust Co SC acquired a new position in DENTSPLY SIRONA during the fourth quarter worth $26,000. Riverview Trust Co acquired a new position in DENTSPLY SIRONA during the fourth quarter worth $26,000. Finally, MassMutual Private Wealth & Trust FSB boosted its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.